Stockscreener 앱 받기
63.85
2.81%
-1.985
전일 마감가:
$65.84
열려 있는:
$65.85
하루 거래량:
1.98M
Relative Volume:
1.04
시가총액:
$31.13B
수익:
$10.63B
순이익/손실:
$819.00M
주가수익비율:
38.52
EPS:
1.6577
순현금흐름:
$1.59B
1주 성능:
-3.21%
1개월 성능:
+0.55%
6개월 성능:
-19.27%
1년 성능:
-24.61%
1일 변동 폭
$63.81
$66.41
1주일 범위
$63.97
$68.02
52주 변동 폭
$61.84
$92.55
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
63.82 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
400.22 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
140.92 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
36.06 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
184.78 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | 개시 | William Blair | Mkt Perform |
| 2026-01-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-12-11 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-08-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-05-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 재확인 | BTIG Research | Buy |
| 2025-03-28 | 재확인 | Needham | Buy |
| 2025-03-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-24 | 재확인 | Needham | Buy |
| 2025-01-10 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 재확인 | Needham | Buy |
| 2024-11-12 | 재확인 | Needham | Buy |
| 2024-10-10 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 개시 | Goldman | Buy |
| 2024-03-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 개시 | Bernstein | Outperform |
| 2023-12-18 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | 업그레이드 | Societe Generale | Sell → Hold |
| 2022-12-22 | 개시 | Mizuho | Buy |
| 2022-11-17 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2022-08-11 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-05-12 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-11 | 개시 | BofA Securities | Buy |
| 2022-01-18 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 개시 | Oppenheimer | Perform |
| 2021-07-14 | 개시 | Deutsche Bank | Buy |
| 2021-05-06 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-03-22 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-11-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-07-06 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-07-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-04-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Argus | Hold → Buy |
| 2020-03-24 | 업그레이드 | Societe Generale | Sell → Hold |
| 2020-03-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-26 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-01-08 | 개시 | Argus | Hold |
| 2019-10-29 | 개시 | Stephens | Equal-Weight |
| 2019-08-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-06-24 | 개시 | SVB Leerink | Mkt Perform |
| 2019-06-14 | 개시 | BTIG Research | Neutral |
| 2019-05-10 | 개시 | Robert W. Baird | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
모두보기
Alcon Inc 주식(ALC)의 최신 뉴스
New contact lens comfort data puts Alcon’s DAILIES TOTAL1 center stage - AD HOC NEWS
New treatment option for cataract surgeons, Alcon Clareon IOL expands premium lineup - AD HOC NEWS
Canadian launch sets the stage for Alcon’s UNITY CS cataract system - AD HOC NEWS
Alcon Inc Stock (CH0432492467): Eye-care leader in focus after recent trading and sector moves - AD HOC NEWS
Alcon launches Unity CS cataract surgery system in Canada - Investing.com
Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada - Eagle-Tribune
Alcon Inc. Stock (CH0432492467): Ownership changes put the eye-care group in focus - AD HOC NEWS
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
Alcon Inc. Stock (CH0432492467): Valuation metrics keep eye-care leader in focus - AD HOC NEWS
Alcon Inc Stock (CH0432492467): Citi reiterates Buy rating and sees upside potential - AD HOC NEWS
Alcon DAILIES TOTAL1 contact lenses: daily comfort for dry-eye wearers - AD HOC NEWS
KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $88 - Moomoo
Alcon (ALC) Gets a Buy from Citi - The Globe and Mail
Citi Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $103 - Moomoo
Alcon Inc Stock (CH0432492467): Analyst targets highlight upside after Q1 update - AD HOC NEWS
Systane class action claims eye drops falsely advertised as preservative-free - Class Action Lawsuits
Alcon Inc. stock (CH0432492467): eye-care specialist steadies after Q1 2026 update - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist steadies after Q1 earnings and dividend update - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after recent earnings and outlook - AD HOC NEWS
Alcon Inc. stock (CH0432492467): eye-care specialist edges higher after Q1 earnings and guidance upd - AD HOC NEWS
Alcon Inc. stock (CH0432492467): Eye-care specialist builds on Q1 earnings momentum - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist in focus after recent earnings update - AD HOC NEWS
BTIG lowers Alcon stock price target to $82 on lower valuation - Investing.com
Alcon faces class-action lawsuit over false product marketing - Eyes On Eyecare
Alcon shares see BofA reiterate underperform on soft Q1 results - Investing.com
Alcon Q1 2026 slides: EPS beats but revenue miss sparks selloff - Investing.com
Alcon Inc stock (CH0432492467): shares steady after Q1 2026 earnings beat and raised guidance - AD HOC NEWS
Swiss eye care firm Alcon's quarterly revenue rises less than expected - marketscreener.com
Is It Too Late to Buy Alcon Inc (ALC) After 3.7% Rally? GF Value Says Undervalued - GuruFocus
Alcon Inc stock (CH0432492467): sector backdrop in focus as shares consolidate - AD HOC NEWS
Alcon Inc. stock (CH0432492467): shares hover in mid-60 USD range on NYSE as investors await next ea - AD HOC NEWS
Alcon Inc. stock (CH0432492467): shares near mid-60 USD range ahead of next earnings update - AD HOC NEWS
Recalled Systane, GenTeal Tears Eye Products Falsely Labeled as ‘Sterile’ Despite Contamination Risks, Class Action Claims - ClassAction.org
Alcon Inc. (ALC) Stock Analysis: Eyeing a 33.54% Potential Upside in the Growing Healthcare Sector - DirectorsTalk Interviews
Alcon Inc stock (CH0432492467): Shares steady as investors digest Q1 2026 results and eye care marke - AD HOC NEWS
Alcon: Product Cycle Reset Creates An Attractive Entry Point (Initiating Buy) (NYSE:ALC) - Seeking Alpha
Alcon Inc. stock (CH0432492467): shares steady as Swiss eye-care group trades near recent highs - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care group holds near USD mid-60s as investors track valuation m - AD HOC NEWS
Alcon Inc. stock (CH0432492467): steady trading ahead of next catalysts and valuation focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Swiss-listed shares slip in line with market - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care group steady as investors watch sector trends - AD HOC NEWS
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now? - TradingView
Alcon stock: Earnings, guidance and lens demand in focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after latest earnings and guidance upda - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist in focus after latest earnings - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after latest earnings update - AD HOC NEWS
Alcon Inc stock (CH0432492467): Q1 2026 earnings beat keeps eye-care specialist in focus - AD HOC NEWS
Southpoint Capital Advisors LP's Alcon Inc(ALC) Holding History - GuruFocus
Evaluating Alcon (SWX:ALC) After Recent Share Price Weakness And Perceived Valuation Gap - Yahoo Finance
Baptista Research Upgrades Alcon to Buy Rating - Moomoo
Does Alcon (SWX:ALC) Offer Opportunity After A 26% One Year Share Price Slide? - Yahoo Finance
Alcon Inc (ALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.59%
자본화:
|
볼륨(24시간):